The Pharmaceutical Care Management Association (PCMA) is fighting back against claims that pharmacy benefit managers are to blame for rising drug prices, FierceHealthcare reports, and has launched a new initiative aimed at educating consumers.
The campaign, #OnYourRxSide, comes on the heels of the Trump administration’s proposal to end the rebate practices between PBMs and pharmaceutical companies.
“PBMs have an established and successful track record of implementing consumer-friendly, market-based tools, such as negotiating with drug manufacturers, to reduce costs for consumers,” PCMA President and CEO JC Scott said in a statement. “This campaign is designed to break through the noise in the drug pricing debate and clearly demonstrate how PBMs are the advocates for consumers in the fight to lower prescription drug costs.”
To read the full report on FierceHealthcare, click here.